Background {#Sec1}
==========

Indigenous Australians experience significant health disparities compared to the non-Indigenous population \[[@CR1]\]. Although Indigenous peoples throughout the world suffer health disadvantages resulting in reduced quality of life, when compared to non-Indigenous people, the health disparity among Indigenous Australians is significant. It is characterised by the high prevalence of preventable disease, including cardiovascular disease (CVD), which has contributed to lower life expectancy of this population \[[@CR2]\]. In adopting its *Closing the Gap* policy, the Council of Australian Governments (COAG) committed to address this inequality. Targets were set for a range of health and wellbeing indicators with the aim of closing the Indigenous life expectancy gap within a generation \[[@CR3]\] Subsequently, many healthcare policies, strategies, and programs have been implemented with the explicit aim to improve Indigenous health.

In this context it is essential to monitor and evaluate the effectiveness of such programs, especially those focused on CVD, which has a higher incidence among Indigenous Australians compared to others \[[@CR4]\] and is the leading cause of morbidity and mortality in this population \[[@CR1]\]. Recent data show little improvement in equity of health outcomes and extensive disparity persists \[[@CR1], [@CR5]\].

Although CVD is largely preventable \[[@CR6], [@CR7]\] it is a major contributor to morbidity, mortality and health disparity worldwide \[[@CR8], [@CR9]\] and there is substantial Australian evidence of its contribution to higher rates of morbidity and mortality among Indigenous Australians \[[@CR2]\]. In 2009, CVD was 4.6 times more prevalent in the Indigenous population than in other Australians \[[@CR10]\]. And, in the most recent Australian burden of disease study, CVD accounted for 12% of the total burden of Indigenous disease, and was responsible for 19% of the gap in total health burden disparity between Indigenous and non-Indigenous Australians \[[@CR1]\]. In 2012 it was reported that Indigenous people are more than 70% more likely to die from CVD than other Australians \[[@CR11]\], and Australian national statistics from 2016 attributed 13% of all Indigenous Australian deaths to CVD \[[@CR12]\]. In addition, the risk factors for CVD are disproportionally higher among Indigenous Australians compared to other Australians. The fourth national report (2012--2016) of Indigenous primary health care national key performance indicators revealed that although there has been a reduction in CVD, most primary healthcare organisations recorded the necessary risk factors to enable CVD assessment for fewer than 50% of their clients \[[@CR13]\]. Although many risk factors are theoretically preventable, effective health promotion campaigns in the Indigenous context are met with challenges such as geographical isolation contributing to lack of access and poor resource distribution, cultural sensitivity issues \[[@CR10], [@CR14], [@CR15]\], and the complexity of disease \[[@CR16]\].

While it is crucial to understand the root causes of Indigenous CVD disparity in terms of the social and economic forces that contribute to, or influence the development of risk factors, it is equally important to formulate strategies that are effective for improving Indigenous health. Cardiovascular health promotion interventions encompass areas such as the definition of the cardiac condition in terms of aetiology, diagnosis of the problem, identification of treatment courses, how to deliver services effectively, expected outcomes in terms of improvements, and maintenance strategies to prevent deterioration of cardiovascular health \[[@CR17], [@CR18]\]. The goal of such programs should be to reduce cardiovascular risk, identify and manage complications, provide appropriate and timely health care, and provide support to Indigenous people in their efforts to modify their lifestyle and self-manage their cardiovascular health \[[@CR19], [@CR20]\].

The disparity between Indigenous and non-Indigenous Australian morbidity and mortality represents an important target for the design and implementation of effective cardiovascular health improvement programs. Opportunities to prevent and enhance treatment and management of CVD for Indigenous people are important if closure of the health gap is to be achieved. In this context it is imperative that effective programs are provided that are best suited to their unique contexts and needs. Programs should take into consideration Indigenous factors that impact health, such as political history and cultural views and beliefs that affect disease understandings. Whilst it is well-recognised that there is much that needs to be done to optimise Indigenous cardiovascular health, at present there is limited evidence of the effectiveness of cardiovascular programs that aim to improve it. Despite the fact that many healthcare programs have been implemented, the majority have been reported descriptively (e.g. \[[@CR21]--[@CR23]\]) and most lack a rigorous approach to evaluation of their effectiveness. Thus, it is unclear which programs have greatest benefit.

An evidence-based summary of the effectiveness of cardiovascular programs for Indigenous people would provide important information to assist with the development and evaluation of future programs. Thus, the aim of this study was to evaluate the effectiveness of interventions focused on the management of cardiovascular health among Indigenous Australians. The review results may guide health professionals and policy makers towards best practices that in turn may help to improve cardiovascular health outcomes for Indigenous Australians. The review question was: How effective are current programs that aim to improve cardiovascular health of Indigenous Australians?

Methods {#Sec2}
=======

Design {#Sec3}
------

A systematic review was conducted based on Joanna Briggs Institute (JBI) guidelines \[[@CR24]\]. Systematic review methodology enables use of rigorous methods to synthesise previous research data in a scientifically sound manner through formulation of a research question; identification, selection, critical appraisal, data extraction and analysis; and presentation of aggregated outcomes of studies included in the review \[[@CR25], [@CR26]\]. The protocol for this review was registered with Prospero International \[[@CR27]\].

Eligibility criteria {#Sec4}
--------------------

This review sought to identify studies within the published peer-reviewed literature that focused on implementation of programs designed specifically for Indigenous Australians, aimed at prevention, treatment or management, or rehabilitation of CVD that were published in English between 2008 and 2017. The date range was selected to identify interventions implemented following the launch of the *Close the Gap* campaign \[[@CR3]\]. Experimental studies eligible for review included both randomised controlled trials and non-randomised studies that measured outcomes associated with the cardiovascular program implemented. The inclusion criteria were:***Population:*** Indigenous participants, and mixed sample studies with a larger proportion of Indigenous participants.***Intervention:*** interventions reporting an explicit aim of prevention, management/treatment, or rehabilitation of cardiovascular disease among Indigenous Australians***Comparator:*** comparisons between intervention and control group or baseline results for single group pre-test and post-test studies.***Outcomes:*** demonstration of changes in, but not limited to: behavioural risk factors (e.g. increased participation in exercise, rehabilitation, and dietary management), knowledge of cardiovascular disease, and health assessment measures (e.g. decrease in blood pressure, weight loss).***Study design:*** all types of experimental (randomised and non-randomised) designs.***Limits:*** peer-reviewed journals; publication date range 2008 to 2017; English language.

Search strategy {#Sec5}
---------------

The search was conducted in two stages. In September 2016 an initial search of CINAHL from 2008 onwards was conducted to estimate the quantity and quality of published articles. This initial search retrieved very few potential articles for inclusion in the review and even fewer randomised controlled trials. Subsequently, librarian colleagues were consulted to assist with refinement of the search terms, to include all experimental (randomised and non-randomised) designs. A comprehensive search strategy was developed, which was implemented from October 2016 to June 2017. It used a combination of MESH terms and text words that was purposely broad to capture the breadth of available studies. The following sources were electronically searched: CINAHL; Pubmed; PsycINFO; Scopus; and Web of Science. A search strategy using all identified keywords with filters was applied for each specific database (see Table [1](#Tab1){ref-type="table"}). A hand search of the reference lists of the selected articles was also conducted.

Study selection process {#Sec6}
-----------------------

The database search results were imported into Endnote™ where duplicates were removed; after which the titles and abstracts were screened by three reviewers to identify studies matching the inclusion criteria. Full texts of potentially relevant studies were retrieved for further assessment against criteria. All outcome data claimed by the original authors to measure the construct of interest were considered eligible for inclusion. Studies were included if they used quantitative measures to examine effectiveness. Mixed method studies were considered if significant quantitative outcomes were reported.

Data extraction and synthesis {#Sec7}
-----------------------------

Quantitative data were extracted from the included studies. One reviewer extracted data using the JBI data extraction form for experimental/observational studies \[[@CR28]\]. Data extracted included: author details; year of publication; study design; sample and setting; methods; intervention description; outcomes; and comments/conclusions. These were cross-checked by two reviewers for completeness and accuracy.

The results are synthesised using a narrative approach supported with tables. Heterogeneity of the studies in terms of interventions, settings, outcome measurements, and study designs precluded conduction of a meta-analysis. Studies were categorised by type of intervention strategy (prevention, management or treatment, or rehabilitation). The focus was on changes that occurred as a result of implementing an intervention and measurement of its impact or effectiveness.

Results {#Sec8}
=======

Study selection {#Sec9}
---------------

The selection process is presented in Fig. [1](#Fig1){ref-type="fig"}. A total of 724 studies was retrieved and 124 duplicates were excluded. 470 articles which were: non-specific to Indigenous Australians, qualitative studies, protocols, reviews, editorials or letters; and 122 articles that were purely descriptive or did not involve strategy implementation, were excluded. Eight studies were included in the full review (see Table [2](#Tab2){ref-type="table"}).Fig. 1PRISMA flow diagram: search and study selectionTable 1Search strategy in CINAHLSearchSearch termsS1 Population of interest((MH "Indigenous Health") OR (MH "Aborigines+") OR (MH "Indigenous Peoples+") OR (Aborigin\* OR Indigenous OR "Torres Strait Islander\*" OR "Australoid race" OR Koori\* OR Murri\* OR "Oceanic ancestry group\*"))S2 Disease((MH "Heart Diseases+") OR (MH "Coronary Arteriosclerosis") OR (MH "Coronary Disease+") OR (MH "Cardiovascular Diseases+") OR (MH "Cardiovascular Risk Factors") OR (MH "Cardiovascular Abnormalities+") OR (MH "Cardiac Patients") OR (Cardiac OR Cardiolog\* OR "Heart disease\*" OR "Heart failure\*" OR Coronar\* OR Cardiovascular OR "Heart health" OR "Heart problem\*" OR "Heart disorder\*"))S3 Intervention((MH "Patient Education+") OR (MH "Diet+") OR (MH "Health Services+") OR (MH "Health Promotion+") OR (MH "Public Health+") OR (MH "Epidemiology+") OR (MH "Treatment Outcomes+") OR (MH "Rehabilitation+") OR (MH "Therapeutic Exercise+") OR (MH "Exercise+") OR (Prevent\* OR Educat\* OR Diet\* OR Exercise\* OR Rehabilitat\* OR "Health Promotion" OR "Treatment outcome\*" OR "Public health" OR Epidemiology))S4 Setting((MH "Australia+") OR (MH "Western Australia") OR (MH "South Australia") OR (MH "Queensland") OR (MH "New South Wales") OR (MH "Australian Capital Territory") OR (MH "Northern Territory") OR (MH "Tasmania") OR (Australia\* OR Queensland OR "New South Wales" OR Victoria OR "Australian Capital Territory" OR "South Australia" OR "Western Australia" OR "Northern Territory" OR Tasmania) NOT (Canada OR Columbia))S6 Design("Randomized controlled trial\*" OR "controlled clinical trial\*" OR "random allocation" OR "double blind method" OR "single blind method" OR "clinical trial\*" OR placebo\* OR random\* OR "research design" OR "comparative stud\*" OR "evaluation stud\*" OR "follow-up stud\*" OR "prospective stud\*" OR "cross-over stud\*" OR (control\* OR prospect\* OR volunteer\*) OR ((singl\* OR doubl\* OR treb\* OR tripl\*) W2 (blind\* OR mask\*)))S6S1 AND S2 AND S3 AND S4 AND S5Table 2Characteristics of included studiesAuthors, yearStudy designStrategy focusInterventionSample and settingMethodOutcomesCommentsBurgess,\
et al., 2011 \[[@CR38]\]Interrupted time series study (6 years); pre- and post-measures; 6-monthly follow ups pre- (3 years) and post-intervention (3 years)Early identification/ preventativeHolistic CVD risk assessment as part of an adult health checkIndigenous participants (*n* = 64); remote primary health care service, Northern TerritoryQuestionnaires/charts review/ investigationsImproved delivery of preventive care services; improved medicine prescription; reduction in estimated absolute CVD risk; better and earlier identification of elevated CVD risk.The program led to better and earlier identification of cardiac risk factors as well as generally improved delivery of preventive care services and cardiac treatmentBurgess,\
et al.,\
2015 \[[@CR36]\]Longitudinal clinical audits of cardiac prevention services; 3 monthly follow-ups for 2 yearsPreventativeChronic conditions management modelIndigenous participants (*n* = 12,428); remote primary health care services (*n* = 49), Northern TerritoryClinical audit of cardiac prevention servicesIncreased coverage of Indigenous population CVD risk assessment; assessment of modifiable cardiac risk factors); increased appropriate prescription of medication; achievement of clinical targets for risk reductionThe program demonstrated ability to reduce cardiac risk factors in rural Indigenous populations. It also enabled follow-up of patientsCanuto,\
et al., 2012 \[[@CR31]\]Pragmatic RCT\
Follow up 3 monthly (completed: *n* = 59, lost to follow up: *n* = 41)Management/ treatment12-week exercise and nutrition programIndigenous participants (intervention *n* = 51, control *n* = 49);\
metropolitan area, South AustraliaImplementation of a structured exercise programReduction in weight and BMILow attendance but intervention had positive effects. Requires understanding the barriers to participationDavey,\
et al., 2014 \[[@CR33]\]Mixed methods\
Pre- and post-program measuresRehabilitation/ secondary prevention8-week supervised exercise and educational session - cardiopulmonary rehabilitation and secondary prevention programIndigenous participants (*n* = 92); Aboriginal community-controlled health services, TasmaniaImplemented an exercise and educational program with Indigenous communityIncreased participation in rehabilitation; positive changes in health behaviours, functional exercise capacity and health related quality of life. Decreased weight, BMI, and waist circumference\
Increased 6-min walk test resultsCommunity based interventions have multiple positive impactsDavidson,\
et al., 2008 \[[@CR34]\]Mixed methods\
Pre- and post-measuresManagement/ treatmentA partnership model among key education providers, policy makers, non-government organisations, the local area health service and Aboriginal community controlled organisationsIndigenous participants (*n* = 21); metropolitan Technical and Further Education (TAFE), New South WalesMixed method evaluation using\
questionnaires and semi structured interviewsParticipants reported increased confidence in ability to provide CVD service to community and demonstrated enhanced CVD knowledge: post-course test mean score 70% vs pre-course score 42%The model was useful in promoting cardiac knowledge in Aboriginal Health Workers while increasing Aboriginal health knowledge in the mainstream health setting. The model forged partnerships.Daws,\
et al., 2014 \[[@CR37]\]Pre- and post -evaluation programRehabilitation/ secondary preventionWorking together model of care - (Aboriginal hospital liaison officer and specialist cardiac nurse team)Aboriginal and Torres Strait Islander participants (*n* = 13); metropolitan tertiary public hospital, VictoriaRetrospective auditIncreased referral rate (15 to 86%)\
and attendance rate (0 to 62%)The partnership model approach to care coordination and system changes that were implemented led to improved attendance at cardiac rehabilitation in the participating groupDimer,\
et al., 2013 \[[@CR35]\]Mixed methods\
Pre- and post-program measuresRehabilitationCardiac rehabilitation program; weekly exercise and education sessionsIndigenous participants (*n* = 48); Aboriginal medical services, Western AustraliaEvaluation of exercise and educational programDecreased weight, BMI, BP, waist girth; improved 6-min walk testAboriginal Medical Service based cardiac rehabilitation proved to be effective in improving attendance, and cardiac risk factor and health managementPeiris\
et al., 2015 \[[@CR32]\]Parallel arm cluster-randomized controlled trialManagement/ treatmentComputer-guided quality improvement interventionAboriginal and Torres Strait Islander participants (*n* = 38,725); Australian primary healthcare centres (*n* = 60 services), New South Wales and QueenslandImplementation of computerised screening and management algorithmThe intervention was associated with improved overall risk factor measurementsThere was minimal support required to implement the tool and had positive effects on improving cardiac risk measurement*BMI* body mass index, *BP* blood pressure, *CVD* cardiovascular disease

Methodological quality of included studies {#Sec10}
------------------------------------------

Studies selected for inclusion in the review were assessed for methodological quality. Three researchers reviewed and assessed each study for quality and relevance, using tools appropriate to its design. Joanna Briggs Institute \[[@CR29]\] checklists for randomised control trials (13 criteria) and quasi-experimental non-randomised studies (9 criteria) were used. Overall quality was graded using categories cited by Reilly et al. \[[@CR30]\] in relation to the proportion of criteria met (poor \< 50%, moderate 50--80%, good \> 80%), but was not used to exclude studies. Any disagreements that arose between reviewers were resolved through team discussion.

The overall weakness of the included studies was a lack of randomised trials; only two studies were found: a pragmatic randomised trial \[[@CR31]\] and a parallel arm cluster randomised controlled trial \[[@CR32]\]. The other six studies were of various designs, of which three employed mixed methods \[[@CR33]--[@CR35]\]. The two randomised studies were judged to be of moderate quality (see Table [3](#Tab3){ref-type="table"}), while four of the quasi-experimental studies were judged to be of good quality, with one assessed as moderate \[[@CR36]\] and another as poor \[[@CR37]\] (see Table [4](#Tab4){ref-type="table"}).Table 3Critical appraisal of randomised controlled trialsJBI checklist criteria (potential bias)StudiesCanuto\
et al., 2012 \[[@CR31]\]Peiris\
et al., 2015 \[[@CR32]\]1. Was true randomization used for assignment of participants to treatment groups? (selection bias)YesYes2. Was allocation to treatment groups concealed? (selection bias)NoNo3. Were treatment groups similar at the baseline? (selection bias/design bias)YesYes4. Were participants blind to treatment assignment? (performance bias)NoNo5. Were those delivering treatment blind to treatment assignment? (performance/detection bias)NoNo6. Were outcomes assessors blind to treatment assignment? (ascertainment bias)NoYes7. Were treatments groups treated identically other than the intervention of interest? (systematic difference/containment bias)YesYes8. Was follow-up complete, and if not, were strategies to address incomplete follow-up utilized? (attrition bias)YesYes9. Were participants analysed in the groups to which they were randomized? (intention to analysis)YesYes10. Were outcomes measured in the same way for treatment groups? (instrumentation/testing effects threats)YesYes11. Were outcomes measured in a reliable way? (measurement bias)YesYes12. Was appropriate statistical analysis used? (performance/detection bias)YesYes13. Was the trial design appropriate, and any deviations from the standard RCT design (individual randomization, parallel groups) accounted for in the conduct and analysis of the trial? (design bias)YesYesTotal (%) and quality rating^a^9/13 (69%)\
Moderate10/13 (77%)\
Moderate^a^Good: at least 80%, moderate: 50--80%; poor: less than 50%Table 4Results of critical appraisal of quasi-experimental studiesJBI checklist criteria (potential bias and threat)StudiesBurgess\
et al., 2011 \[[@CR38]\]Burgess\
et al., 2015 \[[@CR36]\]Davey\
et al., 2014 \[[@CR33]\]Davidson\
et al., 2008 \[[@CR34]\]Daws\
et al., 2014 \[[@CR37]\]Dimer\
et al., 2013 \[[@CR35]\]1. Is it clear in the study what is the 'cause' and what is the 'effect' (i.e. there is no confusion about which variable comes first)? (causation/reverse causation)YesYesYesYesYesYes2. Were the participants included in any comparisons similar? (selection bias)YesYesYesYesYesYes3. Were the participants included in any comparisons receiving similar treatment/care, other than the exposure or intervention of interest? (history threat/systematic difference/ contamination bias)YesYesYesYesYesYes4. Was there a control group? (measurement bias)NoNoNoNoNoNo5. Were there multiple measurements of the outcome both pre and post the intervention/exposure? (maturation threat, regression to the mean)YesNoYesYesNoYes6. Was follow-up complete, and if not, was follow-up adequately reported and strategies to deal with loss to follow-up employed? (attrition bias)YesYesYesYesYesYes7. Were the outcomes of participants included in any comparisons measured in the same way? (instrumentation/testing effects threats)YesYesYesYesNoYes8. Were outcomes measured in a reliable way? (detection/instrument/measurement bias)YesYesYesYesNoYes9. Was appropriate statistical analysis used? (performance/detection bias)YesNoYesYesNoYesTotal (%) and quality rating^a^8/9 (88%)\
Good6/9 (67%)\
Moderate8/9 (88%)\
Good8/9 (88%)\
Good4/9 (44%)\
Poor8/9 (88%)\
Good^a^Good: at least 80%, moderate: 50--80%; poor: less than 50%

With the exception of two studies \[[@CR32], [@CR36]\] samples sizes were small ([\<]{.ul} 100). Two studies compared different cohorts before and after the intervention \[[@CR36], [@CR37]\] whereas the remainder reported repeated measures. Two studies did not report any statistical significance of outcomes \[[@CR36], [@CR37]\] and one \[[@CR33]\] reported several outcomes as being "statistically significant" but did not cite associated values. Only one study \[[@CR33]\] reported effect sizes, but did not provide associated significance values, although it was stated in the text that the outcomes were not statistically significant.

Study characteristics {#Sec11}
---------------------

Considerable heterogeneity of cardiovascular health programs and settings was represented in the eight included studies (see Table [2](#Tab2){ref-type="table"}), which were conducted within the following Australian states and territories: New South Wales \[[@CR34]\]; New South Wales and Queensland \[[@CR32]\]; Northern Territory \[[@CR36], [@CR38]\]; South Australia \[[@CR31]\]; Tasmania \[[@CR33]\]; Victoria \[[@CR37]\]; and Western Australia \[[@CR35]\]. The studies were conducted in several settings: Aboriginal medical services \[[@CR33], [@CR35]\]; metropolitan \[[@CR31], [@CR34], [@CR37]\] and primary care \[[@CR31], [@CR36], [@CR38]\].

Intervention categories were identified following completion of data extraction. There were three strategic intervention foci observed in the studies reviewed: prevention; management or treatment; and rehabilitation (see Table [2](#Tab2){ref-type="table"}). All studies reported some statistically significant positive impacts, which were demonstrated by post-intervention improvements to varying degrees. The main outcomes measured were: increased participation \[[@CR33], [@CR37]\], reduction in physiological indicators, such as blood pressure and body weight \[[@CR31], [@CR35], [@CR36]\], increased confidence of Indigenous staff \[[@CR34]\] and overall improvements in identification and management of cardiac conditions \[[@CR32], [@CR36], [@CR38]\].

Risk of bias within studies {#Sec12}
---------------------------

Bias was distinguished from quality and reflected within the quality appraisal tools (see Tables [3](#Tab3){ref-type="table"} and [4](#Tab4){ref-type="table"}). The included studies were assessed for six main domains; selection bias (randomisation), performance bias (blinding of participants/personnel), detection bias (blinding of outcome measures), attrition bias (incomplete outcome data), reporting bias (selective reporting) and other sources of bias \[[@CR39]\] using the JBI tool quality appraisal tool \[[@CR29]\] as used by Omura et al. \[[@CR40]\].

The two randomised studies \[[@CR31], [@CR32]\] addressed the risk of bias through randomisation, and ensuring that treatment groups were similar at baseline (selection bias) and both specified the randomisation procedures used \[computer Programs for Epidemiologists (PEPI) and permuted block procedure, respectively\]. Both studies addressed performance bias by using appropriate statistical analyses for their studies, but neither blinded those providing treatment or participants. The six other studies had no randomisation allocation. Four were pre- and post-test single group designs, one was a before and after study \[[@CR37]\], and one used a longitudinal design but made comparison to a pre-intervention population \[[@CR36]\]. On the whole, the non-randomised studies used the same measures before and after exposure to the program, on the same participants, and appropriate statistical analyses were used. However, in one study \[[@CR36]\] virtually all outcome measures were post-intervention only, with no statistical analyses undertaken.

The two randomised studies were assessed at level 1.c evidence according to JBI levels of evidence for effectiveness of experimental designs, and the six non-randomised studies were assessed at level 2.d evidence \[[@CR41]\].

Risk of bias across studies {#Sec13}
---------------------------

Risk of bias across studies was conducted to address the following: risk of measurement, detection, attrition, and selection bias as reported earlier (see Tables [3](#Tab3){ref-type="table"} and [4](#Tab4){ref-type="table"}). Randomisation was used to assess selection bias for the two randomised trials; both described procedures for randomisation. Due to the nature of the programs, blinding of those who delivered the program and participants was not possible. One study used a single-blinded design in which outcome assessors were blinded \[[@CR32]\].

Results of individual studies {#Sec14}
-----------------------------

Significant results of individual studies are presented in Table [5](#Tab5){ref-type="table"}. Meta-analysis was not possible due to heterogeneity of the studies.Table 5Significant results of individual studiesAuthor year Study designSample size *n*Model or test usedOutcomesSignificance *p*Effect sizeMeasureResultCanuto et al., 2012\
RCT \[[@CR31]\]*n* = 100\
Exp: *n* = 51\
Con: *n* = 49Regression analysis; adjusted for all potential confounders\
Repeated measures: baseline (T1); immediate post-program (T2); 3 months post-program (T3)T1-T2 mean weight change (kg)\
T1-T3 mean weight change (kg)−1.65 (95% CI -3.27 - -0.03)\
−2.50 (95% CI-4.46 - -0.54)0.046\
0.013NRT1-T2 mean BMI change (kg/m^2^)\
T1-T3 mean BMI change (kg/m^2^)−0.66 (95% CI -1.27 - -0.05)\
−1.03 (95% CI -1.79 - -0.27)0.035\
0.009NRPeiris et al., 2015\
RCT \[[@CR32]\]*n* = 38,725 (60 clusters)\
Exp: *n* = 19,385 (30 clusters); HR cohort *n* = 5392\
Con: *n =* 19,340 (30 clusters); HR cohort *n* = 4916Repeated measures\
Generalized estimating equationsAppropriate screening for CVD (%)Exp: 62.8\
Con: 53.40.02RR 1.25\
(95% CI 1.04--1.50)CVD risk screening small service (\<  500) (%)Exp: 59.8\
Con: 37.30.021.62\
(95% CI 1.17--2.26)HR cohort: antiplatelet medication prescription escalation (%)Exp: 17.9\
Con: 2.7\<  0.001RR 4.80\
(95% CI 2.47--9.29)HR cohort: lipid-lowering medication prescription escalation (%)Exp: 19.2\
Con: 4.8\<  0.001RR 3.22\
(95% CI 1.77--5.88)HR cohort: BP-lowering medication prescription escalation (%)Exp: 23.3\
Con: 12.10.02RR 1.89\
(95% CI 1.08--3.28)HR cohort: proportion obtaining guideline BP targets (%)Exp: 61.0\
Con: 55.00.051.10\
(95% CI 1.00--1.20)Burgess et al., 2011 \[[@CR38]\]\
Quasi*n* = 64Repeated measures\
*t*-test, McNemar's test, ANOVADelivery of CVD preventive services (%)Baseline: 30\
6-month post health check: 53\<  0.001NRProportion of evidence-based CVD services delivered (%)Baseline: 29\
6-month post health check: 57\<  0.001NRPrescription of all CVD related medication (%)Baseline: 28\
6-month post health check: 89\<  0.001NRPrescription of anti-platelet medication (%)Baseline: 4.7\
6-month post health check: 68.3\<  0.001NRPrescription of lipid-lowering medication (%)Baseline: 6.3\
6-month post health check 65.1\<  0.001NRPrescription of ACEi/ARB medication (%)Baseline: 25.0\
6-month post health check: 63.5\<  0.001NRPrescription of oral hypoglycaemic medication (%)Baseline: 17.2\
6-month post health check: 33.30.04NRNumber of cigarettes smoked per day (*n* = 41)At health check: 3.5\
At health check review: 2.6\<  0.001NRWaist circumference (cm) (*n* = 56)At health check: 98.3\
At health check review: 96.40.04NRHDL cholesterol (mmol/L) (*n* = 58)At health check: 1.01\
At health check review: 1.110.001NRRatio of total to HDL (*n* = 58)At health check: 5.7\
At health check review: 5.0\<  0.001NRExpected post health check 5-year CVD risk (%) (*n* = 58)At health check: 3.5\
At health check review: 2.6\<  0.001NRExpected post health check 10-year CVD risk (%) (*n* = 58)At health check: 9.5\
At health check review: 10.2\<  0.001NRMean estimated absolute 10-year CVD risk (*n* = 58)Expected at health check review: 10.2\
Observed at health check review: 8.20.004NRBurgess et al., 2015 \[[@CR36]\]\
QuasiPopulation: 49 primary health care services (*n* = 12,428)\
Sample: CVD risk assessment documented (*n* = 7266)\
HR cohort (*n* = 2586)Post intervention descriptive measures\
No inferential statistical analysesCVD risk assessment: proportion of population (%)Pre: 26.0 (*n* = NR)\
Post: 58.5 (*n* = 12,428)NR--HR cohort (*n* = 2586): BP assessment (%)Post: 93.3 (*n* = 2414)NR--HR cohort (*n* = 2586): medication prescription (%)Post: 66.8 (*n* = 1728)NR--HR cohort (*n* = 2414): achieved BP treatment targets (%)Post: 56.6 (*n* = 1366)NR--HR cohort (*n* = 2586): lipids assessment (%)Post: 96.5 (*n* = 2496)NR--HR cohort (*n* = 2586): lipid lowering medication prescription (%)Post: 54.8 (*n* = 1416)NR--HR cohort (*n* = 2496): achieved lipids treatment targets (%)Post: 39.6 (*n* = 989)NR--HR cohort (*n* = 2340): non-smoking status (%)Post: 50.0 (*n* = 1170)NR--Davey et al., 2014 \[[@CR33]\]\
Quasi*n* = 72Repeated measures\
*t-*testWeight change (kg)−0.8 (95% CI -.0.01 - -1.6)NS -- value NRCohen's *d* = 0.04BMI change (kg m^−2^)−0.3 (95% CI -0.01 - -0.06)NS -- value NRCohen's *d* = 0.04Waist circumference change (cm)−3.6 (95% CI -2.5 - -4.7)NS -- value NRCohen's *d* = 0.22Incremental Shuttle Walk Test change (m)106.2 (95% CI 79.1--133.2)NS -- value NRCohen's *d* = 0.116 Minute Walk Test change (m)55.7 (95% CI 37.8--73.7)NS -- value NRCohen's *d* = 0.11Timed up and go test change (sec)−0.8 (95% CI -0.5 - -1.1)NS -- value NRCohen's *d* = 0.11Quality of life (SF 36) changeGeneral health9.7 (95% CI 4.4--14.9)S -- value NRNRBodily pain7.4 (95% CI 0.5--14.4)S -- value NRNRVitality15.3 (95% CI 9.6--21.1)S -- value NRNRSocial functioning8.5 (95% CI 0.8--16.3)S -- value NRNRRole emotional13.5 (95% CI 1.0--26.1)S -- value NRNRMental health14.2 (95% CI 8.6--19.9)S -- value NRNRDavidson et al., 2008 \[[@CR34]\]\
Quasi*n* = 17Repeated measures\
*t*-tests\
MANOVAKnowledge score (range 1--25)Pre: 9.93 (SD 4.02)\
Post: 17.43 (SD 3.32)\<  0.001NRConfidence in knowledge scorePre: 4.46 (SD 1.84)\
Post: 8.08 (SD 1.60)\<  0.001NRConfidence in skills scorePre: 4.29 (SD 2.75)\
Post: 8.16 (SD 1.84)\<  0.001NRConfidence in communication scorePre: 5.52 (SD 2.39)\
Post: 8.34 (SD 1.69)\<  0.001NRDaws et al., 2014 \[[@CR37]\]\
QuasiPre: *n* = 68\
Post: *n* = 13Retrospective audit\
Descriptive analysis. No inferential statistical analysesReferral for cardiac rehabilitation (%)Pre (*n* = 68): 14.7 (*n* = 10)\
Post (*n* = 15): 86.7 (*n* = 13)NR--Attendance for cardiac rehabilitation (%)Pre (*n* = 10): 0\
Post (*n* = 13): 61.5 (*n* = 8)NR--Dimer et al., 2013 \[[@CR35]\]\
QuasiPopulation *n* = 98\
Sample *n* = 48Repeated measures\
*t*-testBMI (kg m^−2^)Pre: 34.0 (SD 5.1)\
Post: 33.3 (SD 5.2)\<  0.05NRWaist girth (cm)Pre: 112.9 (SD 13.6)\
Post: 108.6 (SD 13.2)\<  0.01NRSample subset (program completion) *n* = 28Systolic BP (mm Hg)Pre: 135 (SD 20)\
Post: 120 (SD 16)\<  0.01NRDiastolic BP (mm Hg)Pre: 78 (SD 12)\
Post: 72 (SD 5)\<  0.05NR6 Minute Walk Test distance (m)Pre: 296 (SD 115)\
Post: 345 (SD 135)\<  0.01NR*ACEi* angiotensin converting enzyme, *ARB* angiotensin receptor blocker, *BMI* body mass index, *BP* blood pressure, *Con* control, *CVD* cardiovascular disease, *Exp* experiment, *HDL* high density lipoprotein, *HR* high risk, *NR* not reported, *Quasi* quasi-experimental study, *RCT* randomised controlled trial, *RR* relative risk, *S* significant, *SD* standard deviation

Description of studies {#Sec15}
----------------------

Two studies were specifically focused on preventative programs \[[@CR36], [@CR38]\], providing a combination of primary and secondary prevention interventions, including CVD risk assessment \[[@CR36]\], and holistic risk assessment \[[@CR38]\]. The main outcomes measured included coverage of CVD risk assessment for the Indigenous population, appropriate prescription of medication, achievement of clinical targets (such as reduction of blood pressure and weight), and exercise tolerance.

Implementation of CVD risk assessment opportunities in remote Indigenous communities was conducted in the Northern Territory using a holistic approach as part of an adult health check in a primary health care service \[[@CR38]\]. The intervention provided a 'one-stop-shop' for participants that included provision of transport services to facilitate access. The aim of this six-year interrupted time series study was to identify whether risk assessment led to better identification of elevated CVD risk, improved delivery of preventative services, and improved the CVD risk profile of participants. The results demonstrated that adult health checks were effective in the early identification of CVD with 24.9% (*n* = 75/301) of patients identified as having elevated risk, of whom 64 participated in the study. Compared to baseline, significant improvements in CVD-related medication prescription rates (*p* \<  0.001) were observed at 6-month follow-up. As well, significant improvements in CVD risk factors were demonstrated at health check review follow-up (on average, around a year following initial health check): waist circumference reduction (*p* = 0.04) and HDL cholesterol reduction (*p* = 0.001), with significant reduction in expected versus observed mean estimated 10-year CVD risk (*p* = 0.004). A high level of engagement of Indigenous participants was observed, with the majority undergoing care planning (98%) and pharmacotherapy (89%) by the study end.

In a longitudinal study, conducted over 2 years, a *Chronic Conditions Management Model* was implemented, based on early recognition of CVD \[[@CR37]\]. The model focused on improving the prevention, early detection and management of chronic conditions by introducing strategies such as an information system using an electronic health record offering easy access patients, cardiovascular risk assessments, structured care pathways, and standardised treatment manuals. Although CVD prevalence increased with age, 9% of those aged between 20 to 34 years were found to have a high level of cardiovascular risk. Subjects aged 75 years or more were excluded from the analyses as they were categorised as high risk by default. Due to the relatively young age of Indigenous people, the majority of participants were aged less than 45 years. Following implementation, the Indigenous population coverage of cardiovascular risk assessment doubled from 26 to 58.5%. Whilst post-intervention outcomes were reported (medication prescription, and CVD clinical targets, such as blood pressure), no comparisons were made with pre-intervention counterpart measures, thus it is difficult to judge the significance of the reported results.

Three studies addressed management or treatment interventions \[[@CR31], [@CR32], [@CR34]\]. A pragmatic randomised study in a South Australian urban setting focused on the effects of a structured exercise and nutrition program \[[@CR31]\]. Through education, participants were equipped with relevant knowledge to facilitate self-management of their condition and reduce complications. The program aimed to evaluate the effectiveness of a twelve-week structured exercise and nutrition program in a cohort of urban Indigenous Australian women on waist circumference, weight and biomedical markers of metabolic functioning. Participants were randomly assigned to an experimental 'active' group or a 'waitlisted' control group. Although the sample size was small (*n* = 100), statistically significant outcomes were demonstrated in weight reduction (*p* = 0.046; 0.013) and associated body mass index reduction (*p =* 0.035; 0.009), over time. Although small reductions in blood pressure were achieved (1.24 mmHg, 2.46 mmHg), though considered clinically significant, they were not statistically significant (although incorrectly reported in the abstract as such).

A parallel arm cluster randomised controlled trial was conducted in 60 Australian primary healthcare centres, which implemented a computer-guided tool for the management and treatment of CVD in the Indigenous population \[[@CR32]\]. The tool was effective due to the provision of systematic, step-by-step guidance; practitioners were able to manage patients more effectively and efficiently. And, although the intervention achieved positive outcomes (improved CVD risk screening, *p* = 0.02; improved CVD-related medications escalation, *p* \<  0.001 to 0.02), prescription rates per se did not improve, and effectiveness was limited by the availability of sites with computer access. CVD risk screening was significantly better in smaller healthcare centres (\< 500 patients) than larger ones (*p* = 0.02).

Davidson et al. \[[@CR35]\] sought to improve the confidence of Aboriginal Health Workers in their ability to provide CVD services to their communities. They implemented an educational program that involved multi-sectoral departments such as key education providers, policy makers, and local Aboriginal community-controlled organisations. The education program, facilitated via a Tertiary and Further Education (TAFE) institution, offered experiential learning with participants (*n* = 21) working together as a team, facilitated by a mentor. Outcomes were assessed using a 25-item knowledge test and a confidence survey with three subscales (knowledge, skills, communication), with statements assessed using a Likert-type scale (number of items not reported). Four course participants did not participate in the evaluation (reasons not given), resulting in a small sample size (*n* = 17). The authors reported that participants increased their CVD knowledge (*p* \<  0.001) and confidence in their CVD knowledge, skills, and communication (*p* \<  0.001). However, statistical differences in the latter scores were assessed using *t*-tests, which should be reserved for use with normally distributed scale data. The involvement of various partners had a positive impact by exposing participants to different clinical situations and learning opportunities. This collaborative approach to education facilitated increased cultural competence and expertise in the delivery of cardiovascular services to Indigenous communities.

Three studies investigated rehabilitation programs \[[@CR33], [@CR35], [@CR37]\]. One study was conducted over an eight-week period within a cardiopulmonary rehabilitation centre in Tasmania \[[@CR33]\]. The program was managed by Aboriginal community controlled health services, and included peer support from an Indigenous health worker. Recommendations from family and friends enabled new participants to join. Indigenous participants were provided with easy access via provision of transport services. The program was comprised mainly of supervised exercise and education sessions, with the latter focused on cardiovascular and respiratory health and disease, self-management, benefits of exercise, nutrition, medication usage, stress management and psychological well-being, and smoking cessation. These aspects of intervention were directed towards both prevention and maintenance of health behaviours. The outcome measures included participation level, development of positive health behaviours, and improved general health with improved exercise tolerance. Although there was 22% loss to follow up, resulting in a relatively small sample size (*n* = 72), implementation of this program resulted in "clinically significant" improvements in several measures of cardiovascular health. Reductions in weight loss, waist circumference, and BMI were demonstrated, but were reported as statistically non-significant, although some cited effect sizes were medium to large. As well, Six Minute Walk Test distance, Incremental Shuttle Walk Test distance, and Timed Up and Go Test time were all increased, but were not statistically significant. Quality of life was also improved in most domains of the SF-36; although improvements were reported as "statistically significant" no values were cited. Success was attributed to a well-designed, one-stop-shop. The program had a holistic approach that addressed several health issues such as nutrition, exercise, smoking cessation and medication management. The program also addressed issues of cultural safety by conducting the study in an Aboriginal community controlled health service.

The study by Daws et al. \[[@CR37]\] implemented a "working together" model of care in which an Aboriginal Hospital Liaison Officer and a specialist cardiac nurse teamed up to address the problem of referring patients to rehabilitation services post-acute care. The Aboriginal Hospital Liaison Officer made the initial contact with all patients and facilitated their meeting with the cardiac nurse. This introduction was vital for establishing relationships. Together, the partnership arranged referrals and provided education about the benefits of cardiac rehabilitation, and helped improve access to cardiac rehabilitation health services for the Indigenous participants. Retrospective medical chart audits revealed that the model improved referrals from 15 to 86% and rehabilitation attendance rates from zero to 62%. However, it is important to note that pre-implementation data were collected over a 3-year period (*n* = 68), whereas post-implementation data (*n* = 15) were collected over a 7-month period, and no comparisons were made between the two cohorts. Thus, it is difficult to draw conclusions about the effectiveness of this project. In a similar project, within an Aboriginal medical service, Dimer et al. \[[@CR35]\] aimed to provide a secure environment for an eight-week exercise and education program for Aboriginal people with or at risk of CVD. Both visual and experiential learning opportunities were employed. Education and exercise through yarning helped to identify and address a range of issues such as medication compliance, risk factor reviews, and chest pain management. The cardiac rehabilitation program was well attended (*n* = 98), but only half of the participants (49%, *n* = 48) was surveyed (reasons not given). Of these, outcome measures were reported on 28 participants that completed the 8-week program only, thus it is difficult to evaluate overall effectiveness of the program as the outcome data reported is representative of only 29% of all program participants. In the program-completion subset, statistically significant reductions in body mass index (*p* \<  0.05), waist girth (*p* \<  0.01), systolic (*p* \<  0.01) and diastolic (*p* \<  0.05) blood pressure, and increased 6-Minute Walk Test distance (*p* \<  0.01), were reported. Success of the program was attributed to the delivery of the program in a culturally safe environment. The researchers concluded that rehabilitation programs for Indigenous people were more effective when they were planned as part of an already established service. The program enabled local community members to be involved in the planning of activities.

Discussion {#Sec16}
==========

The aim of this review was to systematically examine the published literature for evidence of the effectiveness of cardiovascular health interventions designed for Indigenous Australians. Eight studies were identified that met the inclusion criteria, demonstrating the dearth of formal research in this area.

There was considerable heterogeneity within the studies that were reviewed with interventions implemented in a wide variety of clinical settings across Australia, and measuring different outcomes. Thus, a meta-analysis was not possible. In order to examine the effectiveness of the interventions, there is a need for further experimental research to demonstrate objectively the effects of cardiovascular programs in terms of health outcomes as well as Indigenous engagement and satisfaction.

Although there was only a relatively small number of intervention studies available for review, the overall results indicate that targeted cardiovascular programs are effective in improving clinical outcomes, such as weight reduction, blood pressure control, and increased activity levels. As well, several programs demonstrated behavioural impacts regarding healthy lifestyle changes, and provided valuable insights into successful strategies for Indigenous people that may help to inform future programs. Indigenous people display cardiovascular symptoms at a younger age compared to non-Indigenous people \[[@CR1]\]. However, poor screening of young Indigenous people has been reported \[[@CR23]\], suggesting a need for earlier targeted assessment and advice about CVD risk factors, commencing during school years.

Although much higher rates of cigarette smoking have been reported for Indigenous Australians \[[@CR1]\], intervention programs addressing this risk factor in association with CVD were not found in this review. Similarly, findings by Arjunan and colleagues \[[@CR42]\] revealed the scarcity of local evidence crucial for promoting cessation among Aboriginal tobacco smokers. The risk to health from smoking and alcohol is widely acknowledged. In particular, smoking impacts cancer, respiratory, and cardiovascular diseases \[[@CR1]\] whereas Indigenous alcohol use is primarily associated with impacts on mental health \[[@CR1]\].

In the main, it was observed that the reviewed programs were designed within a mainstream health model with somewhat limited consideration given to the perspectives of Indigenous patients, their families or communities, suggesting that there is a cultural sensitivity gap in the design of cardiovascular interventions. Culturally sensitive health care has been described as care that effectively responds to the attitudes, feelings, and circumstances of individuals that belong to a population group with common identifying characteristics such as race, religion, language, and socioeconomic status, and that which patients perceive as being concordant with their cultural values and beliefs \[[@CR43]\]. Cultural sensitivity is, therefore, the extent to which ethnic or cultural characteristics, experiences, norms, values, behavioural patterns and beliefs of the target population as well as relevant historical, environmental, and social forces are incorporated into the design, delivery, and evaluation of targeted health programs \[[@CR44]\]. In 2016, the World Federation of Critical Care Nurses made a declaration about culturally sensitive practice \[[@CR45]\]. Its recommendations, whilst directed at critical care nurses, are applicable to many settings. Included are aspects such as self-assessment by clinicians, establishing trust with patients and their families, identification of patients' culture (language, food, gender considerations), and ensuring that dignity and privacy are protected.

Since the focus of the review was on the Indigenous population, each study was reviewed in this context by examining its aims and objectives, its focus on Indigenous participation, and particular Indigenous-sensitive aspects reflected in the design and implementation of its CVD program: access, empowerment, collaborative partnerships, and meaningful relationships. Following their 2012 study on effects of exercise and nutrition, Canuto et al. \[[@CR46]\] went a step further by evaluating their program qualitatively. A main finding was that participants' perception of health benefits of the program influenced their attendance. They concluded that programs should be designed to meet participants' needs and expectations, and be conducted in a culturally safe environment. Healthcare providers should commit to the process of building and maintaining cultural relationships \[[@CR47]\]. Neuwelt and colleagues, \[[@CR48]\] in their study of the role of receptionists in general practice settings, revealed the importance of creating meaningful relationships with Indigenous patients. The receptionists helped patients to feel comfortable, demonstrating that trustworthiness and healthy relationships with patients are important factors that encourage sustained Indigenous engagement. Similarly, Hayman and colleagues \[[@CR49]\] pointed to the fact that successful implementation of programs at a community controlled health centre was partly as a result of employment of Indigenous staff, good interpersonal relationships, and effective collaboration and consultation processes with the Indigenous community.

In several studies, Indigenous access was enhanced by use of local community based services \[[@CR31], [@CR35], [@CR36], [@CR38]\] providing a one-stop-shop type of service \[[@CR38]\]. Further, transportation was offered for those that needed it, enabling access for those living in more remote areas \[[@CR33], [@CR34]\]. A study by Tuttle, et al. \[[@CR50]\] made comparison between Indigenous and non-Indigenous participants in an outreach program to measure completion of scheduled outreach visits of the intervention group. An interesting finding was that distance alone did not influence completion of visits. Although Indigenous participants resided further away from the hospital in comparison to non-Indigenous participants, the study revealed that there was no difference in the number of attempted and missed visits at baseline. A combination of distance and timing of the visits had a significant impact in that at six months visits there were more missed appointments. A similar pattern was also reflected in the study by Artuso et al. \[[@CR51]\] who investigated the factors that influenced utilisation of health care among Indigenous cardiac participants. They found that the perceived need for the service influenced long term utilisation. Patients that felt they were 'fixed' or cured after a procedure, or in this case a program, they did not see the need to continue with treatment. The authors concluded that it was not sufficient to only provide a program but to understand the needs of individuals; emphasising to participants that health maintenance is a lifelong commitment.

Indigenous empowerment was enhanced both at individual and community levels, through use of individualised care plans \[[@CR32], [@CR36], [@CR38]\], training of Indigenous workers \[[@CR34], [@CR37]\], and involvement of community advisory committees \[[@CR31], [@CR35], [@CR37]\], and 'working together' approaches between multidisciplinary teams developed meaningful collaborative partnerships \[[@CR31], [@CR34]--[@CR36], [@CR38]\]. Multidisciplinary teams allowed for focused use of approaches that addressed Indigenous needs and team learning allowed for a better work environment \[[@CR33], [@CR38]\]. Continuity of care was possible with teamwork approaches \[[@CR31], [@CR35], [@CR37], [@CR38]\] and relationships that were appropriate and culturally safe were achieved through involvement of participants and their community \[[@CR34], [@CR35], [@CR37]\]. Providing time to understand participants through yarning and other communication styles that are sensitive to Indigenous people contributed to a culturally safe environment \[[@CR33]--[@CR35], [@CR37], [@CR38]\]. Common components associated with intervention effectiveness were: integration and coordination of programs within the existing services, such as metropolitan areas \[[@CR31]\], primary health services \[[@CR32], [@CR36], [@CR38]\], Aboriginal medical services \[[@CR33], [@CR35]\], active involvement of Indigenous health workers in the form of education and clinical partnerships with other health care providers \[[@CR34], [@CR37]\], and provision of support to facilitate individual participation through transport provision, peer/family support, and professional support \[[@CR33], [@CR38]\].

Our results indicate that an Indigenous perspective was crucial to not only deliver apposite strategies, but to ameliorate the subtle negative impact that colonisation exerts on Indigenous people, reminiscent of the initial forced changes in lifestyle, familial and cultural practices, and spiritual disconnectedness which affect Indigenous people in complex ways \[[@CR14], [@CR52]\]. Indigenous engagement was recommended in the studies, where findings illustrated that whilst the distance from health services influenced Indigenous access, there were other culturally rooted factors that contributed to success and required negotiation of meeting times and locations with the patients. Similar factors were reflected in a narrative report of an Indigenous cardiac outreach program in which success was attributed to integration of Indigenous values, which encouraged capacity building, and ownership of programs by either individuals or communities \[[@CR21]\]. Our results suggest there is a clear need to employ healthcare strategies that incorporate traditional knowledge, and reflect Indigenous values. Without appropriate cultural and contextual knowledge, participants may hold mistaken beliefs about their health outcome, leading to a failure of some participants to engage.

The continued use of mainstream healthcare models displays subtle patronising implications, where traditional knowledge is not adequately acknowledged nor utilised when addressing health issues. Valuing and integrating Indigenous wisdom into the design of healthcare programs can enhance therapeutic relationships between Indigenous communities and health services by uniting and empowering both Indigenous and non-Indigenous peoples as contributors to health \[[@CR53], [@CR54]\]. The key to effectiveness of collaborative partnerships lies in genuine involvement of Indigenous people and validation of traditional practices and influences on policy \[[@CR55]\]. For example, 'working together' programs in multidisciplinary teams have shown demonstrable benefits for participants \[[@CR34], [@CR37]\]. Such programs provide opportunities for learning and create a respectful and reciprocal relationship through genuine understanding by incorporating Indigenous worldviews and cultural preferences \[[@CR56]\]. However, whilst cultural sensitivity is important in the prevention and treatments of behavioural ailments caution has been expressed \[[@CR55], [@CR57]\] that it should not be used as a buzz word or in a tokenistic way.

Although there was only a relatively small number of intervention studies available for review, the overall results indicate that targeted cardiovascular programs are effective in improving clinical outcomes, such as weight reduction, blood pressure control, and increased activity levels. As well, several programs demonstrated behavioural impacts regarding healthy lifestyle changes, and provided valuable insights into successful strategies for Indigenous people that may help to inform future programs.

Implications for indigenous health care services {#Sec17}
------------------------------------------------

The results of this review provide a clear indication of the importance of Indigenous inclusivity and cultural sensitivity when implementing programs aimed at improving Indigenous CVD outcomes. To make a difference in improved health outcomes for this population group, sustainable interventions and continued development of new models of care that meet and manage Indigenous peoples' health needs is critical. This has implications for healthcare professional training and education, which should serve to enhance understanding of differences in individuals that seek health care, especially Indigenous people, emphasising the importance of constructing meaningful relationships and 'working together' approaches. This responsibility transcends departmental boundaries to the general public. For effective programs to be implemented and sustained, rigorous research methods and appropriate programs that are responsive to Indigenous issues and needs will enhance change and impact Indigenous health outcomes positively.

Limitations {#Sec18}
-----------

There were two key limitations to this review. Of particular note was the lack of randomised trials, which would have provided stronger evidence of the effectiveness of interventions. As well, there was significant heterogeneity of settings, interventions and outcomes in the studies that were reviewed, making generalisation difficult. Despite these limitations, some clear themes were evident regarding Indigenous inclusivity and its association with successful outcomes, including both physical and behavioural components.

Conclusions {#Sec19}
===========

There are very few studies that have investigated the effectiveness of cardiovascular health interventions designed to address Indigenous health outcomes. Further rigorous evaluation would enable a better understanding of effectiveness and sustainability of cardiovascular programs among Indigenous Australians. Nonetheless, the reviewed interventions have demonstrated a range of tangible benefits and provided insight into factors that contribute to the success of such programs. Our results suggest that healthcare professionals should actively incorporate the values of Indigenous people into the design of cardiovascular healthcare programs, demonstrating respect and reciprocity through meaningful collaboration with Indigenous people. Clearly the synergy of multidisciplinary teams and collaborative partnerships benefits both patients and health staff alike in a way that can only advance cardiovascular health for Indigenous Australians.
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